TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
0.2200
+0.0280 (14.58%)
At close: Apr 25, 2025, 4:00 PM
0.2250
+0.0050 (2.27%)
Pre-market: Apr 28, 2025, 6:45 AM EDT
TNF Pharmaceuticals Market Cap
TNF Pharmaceuticals has a market cap or net worth of $2.23 million as of April 28, 2025. Its market cap has decreased by -62.22% in one year.
Market Cap
2.23M
Enterprise Value
-6.28M
1-Year Change
-62.22%
Ranking
Category
Stock Price
0.22
Market Cap Chart
Since January 24, 2014, TNF Pharmaceuticals's market cap has decreased from $25.90M to $2.23M, a decrease of -91.39%. That is a compound annual growth rate of -19.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 2.20M | -31.25% |
| Dec 31, 2024 | 3.20M | -75.76% |
| Dec 29, 2023 | 13.20M | -70.93% |
| Dec 30, 2022 | 45.40M | -80.10% |
| Dec 31, 2021 | 228.10M | 1,196.02% |
| Dec 31, 2020 | 17.60M | 935.29% |
| Dec 31, 2019 | 1.70M | -87.94% |
| Dec 31, 2018 | 14.10M | 984.62% |
| Dec 29, 2017 | 1.30M | -87.50% |
| Dec 30, 2016 | 10.40M | 67.74% |
| Dec 31, 2015 | 6.20M | -68.69% |
| Dec 31, 2014 | 19.80M | -23.55% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |